Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiovascular Disease
Health and Advocacy Leaders Mobilize to Bring Attention to Atrial Fibrillation, a Costly and Misunderstood Cardiovascular Disease
June 7th, 2009
As the nation's 76 million Baby Boomers approach their Medicare years, a diverse group of healthcare leaders today joined together to launch AF Stat(TM): A Call to Action for Atrial Fibrillation (AF Stat), and announce the formation of the AF Stat Working Group. This first-of-its-kind, national initiative aims to elevate understanding, diagnosis and management of atrial fibrillation (AFib) among all those affected by this serious and increasingly prevalent cardiovascular disease. Approximately 2.5 million Americans currently have AFib, but because the risk increases with age, this number is expected to rise dramatically as the U.S. population gets older(1)....
Source: Pharma Investments, Ventures & Law Weekly (2009-06-07)
|
